You are here

Algernon Pharmaceuticals Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
AGN
CSE Index: 
Currency: 

Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.

You are here

Algernon Pharmaceuticals Inc. (AGN)

SEDAR Information

Company Info

Address
Suite 915 - 700 West Pender Street
Vancouver, BC V6C 1G8
Canada
Phone
604-398-4175
Ext
701
Email
chris@algernonpharmaceuticals.com
Website
http://www.algernonpharmaceuticals.com
Listing date
Monday, February 1, 2016
Transfer Agent
AST Trust Company (Canada)
Auditor
Smythe LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
1,678,809
Reserved for Issuance: 
54,407,694

Bulletins

18/11/2021

2021-1131 – Consolidation - Algernon Pharmaceuticals Inc. (AGN)

Le 18 novembre/November 2021

Algernon Pharmaceuticals Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every one hundred (100) pre-consolidated common shares.

As a result, the outstanding shares of the company will be reduced to approximately 1,678,809 common shares.

The name and symbol will not change.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2021-12-09-Nation-Builder-of-the-Year-Award-2021_Website.jpg

2021 Nation Builder of the Year Award

Thursday, December 9, 2021 -
12:00pm to 1:00pm
JM_DigitalBanners_VRIC_Website.jpg

Vancouver Resource Investment Conference (VRIC)

Sunday, January 16, 2022 - 8:30am to Monday, January 17, 2022 - 5:30pm
Can-Securities-Exchange_PDAC22_web-740x374_Website.jpg

90th Annual PDAC Convention 2022

Monday, March 7, 2022 to Friday, March 11, 2022